Log in to save to my catalogue

Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory...

Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_458022

Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms

Publication information

Publisher

Singapore: Springer Singapore

More information

Scope and Contents

Contents

The infusion of coronavirus disease 2019 (COVID-19) patients with mesenchymal stem cells (MSCs) potentially improves clinical symptoms, but the underlying mechanism remains unclear. We conducted a randomized, single-blind, placebo-controlled (29 patients/group) phase II clinical trial to validate previous findings and explore the potential mechanis...

Alternative Titles

Full title

Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_swepub_ki_se_458022

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_swepub_ki_se_458022

Other Identifiers

ISSN

1001-0602

E-ISSN

1748-7838

DOI

10.1038/s41422-021-00573-y

How to access this item